Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02705469 · ClinicalTrials.gov registry record · Phase 1
A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 1 study, sponsored by Zenith Epigenetics.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT02705469: Completed Phase 1 study, sponsored by Zenith Epigenetics.
NCT02705469 is a Phase 1 study that has completed, run by Zenith Epigenetics. The registered enrollment target is 44 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02705469, a Phase 1 study, has completed, sponsored by Zenith Epigenetics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
This is an open label, Phase 1, dose escalation and dose confirmation study of ZEN003694 in patients with mCRPC.
Primary Outcome
A DLT is a treatment-related, clinically significant adverse event or laboratory abnormality occurring during the first cycle of treatment (Day 1 thru Day 28).
Interventions
- DRUG ZEN003694
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-10 |
| Phase | Phase 1 |
What the finished NCT02705469 record still lists
NCT02705469 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower).
The record links to 0 conditions, and to 1 intervention - of which ZEN003694 is the first listed.
NCT02705469 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02705469 about?
NCT02705469 is a clinical study titled "A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer". This is an open label, Phase 1, dose escalation and dose confirmation study of ZEN003694 in patients with mCRPC.
What is the current status of trial NCT02705469?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2016-05. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02705469?
The interventions under investigation include: ZEN003694 (DRUG).
Who is sponsoring clinical trial NCT02705469?
This trial is sponsored by Zenith Epigenetics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02705469's enrollment target sits among peer trials
44 1086th of 2000 higher than 901 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia